Fertility Preservation Urged for Young

Each year, roughly 400,000 new cancer cases are diagnosed in children and adolescents globally. With 10-year survival rates now at 80%, experts writing in a medical commentary stress that preserving future fertility must become a standard part of care for these young patients.

Survivors frequently report infertility as one of the most distressing long-term effects of their treatment. Yet, according to the source, fertility preservation is still not offered to all who are eligible. National and international guidelines unanimously recommend early discussions about these options.

The Critical Need for Tissue Freezing

Chemotherapy, radiotherapy, and newer agents like immune checkpoint inhibitors pose a high risk of infertility. For post-pubertal patients, freezing sperm, eggs, or embryos is standard. These methods are not viable for prepubertal children, however. They may also be unsuitable for some older patients if urgent treatment leaves no time for ovarian stimulation.

In these cases, cryopreserving ovarian or testicular tissue is the only available option. Without access to such services, the chance for genetically related children can be lost forever once treatment begins. This compounds the psychological burden of a serious diagnosis.

How Tissue Preservation Works

Ovarian tissue cryopreservation involves surgically removing part or all of an ovary to freeze the cortex, which contains follicles. Later, the tissue can be re-transplanted to restore function. The source states that since 2004, over 200 children have been born worldwide following this procedure.

Testicular tissue cryopreservation requires an open biopsy to obtain tissue for freezing. While live births have been achieved in primates using re-transplanted tissue, the technique is yet to be proven in humans. The first human re-transplantation has been reported, and a UK clinical trial has been approved. Tissue is currently stored in hope of future scientific progress.

Barriers to Access and Promising Models

These are specialised services needing expert teams. The source highlights that access is uneven, affected by factors like age, ethnicity, socioeconomic status, and location. Funding is a major hurdle. In insurance-based systems like the United States, coverage is inconsistent, creating financial barriers. Germany introduced reforms in 2019 requiring insurance coverage for medically indicated preservation.

In publicly funded systems like Canada and the UK, the absence of nationally commissioned services can lead to discretionary local funding. The UK uses a 'hub and spoke' model to improve geographic access. Specialist centres coordinate with local hospitals, enabling tissue storage for over 2,700 children and young adults in the UK. Among European centres, 95 live births have been reported from ovarian tissue re-transplantation.

Clear legal frameworks are also needed for issues like consent for children and long-term storage responsibilities. The source notes that in France, preservation is written into the public health code, but referral remains inconsistent, showing legislation alone is insufficient.

The Power of Coordinated Networks

Globally, only four countries, the United States, Canada, Brazil, and Australia, have integrated oncofertility networks into public health policy. Networks like FertiPROTEKT in German-speaking Europe and NORDFERTIL in the Nordic region coordinate services. The commentary states that such networks have been shown to increase pregnancy rates in cancer survivors.

Only a small number of countries, including Japan and Australia, maintain fertility preservation registries to track outcomes. The authors argue that prospective registries are crucial for quality control and research. International collaboration allows established networks to support emerging services in lower-income countries with training and protocol development. Long-term, multidisciplinary follow-up care is essential to manage the reproductive health of survivors, including monitoring for premature ovarian insufficiency.